| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/07853890802609542 |
| P8608 | Fatcat ID | release_i5fhbs73vnbkzlj3n35uxwjhs4 |
| P698 | PubMed publication ID | 19165643 |
| P5875 | ResearchGate publication ID | 23934753 |
| P50 | author | Erja Kerkelä | Q39399909 |
| Jari Hyttinen | Q47236912 | ||
| Jarno M.A. Tanskanen | Q64225454 | ||
| Heli Skottman | Q110771573 | ||
| Mika Pietilä | Q114378839 | ||
| P2093 | author name string | Katriina Aalto-Setälä | |
| Markku Pelto-Huikko | |||
| Riitta Suuronen | |||
| Mari Pekkanen-Mattila | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart | Q28190508 | ||
| Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes | Q28345594 | ||
| Derivation of Embryonic Stem-Cell Lines from Human Blastocysts | Q29999326 | ||
| Distinct differentiation characteristics of individual human embryonic stem cell lines | Q33253252 | ||
| A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells | Q34209709 | ||
| Characterization of human embryonic stem cell lines by the International Stem Cell Initiative | Q34638055 | ||
| Differences between human embryonic stem cell lines | Q36579000 | ||
| Human embryonic stem cell stability | Q36672105 | ||
| Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling | Q36767598 | ||
| Challenges and approaches to the culture of pluripotent human embryonic stem cells | Q36825868 | ||
| Marked differences in differentiation propensity among human embryonic stem cell lines | Q40012772 | ||
| Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. | Q40049819 | ||
| Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability | Q40191122 | ||
| Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes | Q40202347 | ||
| Cardiomyocytes from human embryonic stem cells: more than heart repair alone | Q40212238 | ||
| Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes | Q40283525 | ||
| Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. | Q40344751 | ||
| Gene expression signatures of seven individual human embryonic stem cell lines | Q40388563 | ||
| Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures | Q40417055 | ||
| Single inner cell masses yield embryonic stem cell lines differing in lifr expression and their developmental potential. | Q40424752 | ||
| Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. | Q40442597 | ||
| Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes | Q40550123 | ||
| Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization | Q40641800 | ||
| Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells | Q40648427 | ||
| Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells | Q41698260 | ||
| Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells | Q44145594 | ||
| Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. | Q47575065 | ||
| Sox1 acts through multiple independent pathways to promote neurogenesis | Q47694196 | ||
| Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion | Q49047090 | ||
| Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2. | Q51062607 | ||
| Testing of nine different xeno-free culture media for human embryonic stem cell cultures. | Q51081053 | ||
| Bone morphogenetic protein-4 enhances cardiomyocyte differentiation of cynomolgus monkey ESCs in knockout serum replacement medium. | Q51099031 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiology | Q10379 |
| P304 | page(s) | 360-370 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines | |
| P478 | volume | 41 |
| Q30537357 | 2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture |
| Q33564271 | A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells |
| Q33961690 | A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. |
| Q27349038 | A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability |
| Q28533644 | Cardiomyocyte MEA data analysis (CardioMDA)--a novel field potential data analysis software for pluripotent stem cell derived cardiomyocytes |
| Q38042792 | Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility |
| Q37844011 | Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review. |
| Q38077159 | Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes |
| Q34465393 | Culture conditions affect cardiac differentiation potential of human pluripotent stem cells |
| Q39736281 | Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization |
| Q38000939 | Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells |
| Q36632323 | Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes |
| Q37542604 | Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells |
| Q39536109 | Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2. |
| Q42706418 | Ginsenosides may enhance the functionality of human embryonic stem cell-derived cardiomyocytes in vitro |
| Q36160823 | HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications |
| Q30540471 | HLA engineering of human pluripotent stem cells |
| Q39129176 | Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype |
| Q92219325 | Increased Neuronal Differentiation Efficiency in High Cell Density-Derived Induced Pluripotent Stem Cells |
| Q38819976 | Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? |
| Q38548660 | Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. |
| Q39576495 | Mesenchymal differentiation propensity of a human embryonic stem cell line. |
| Q39117206 | Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells |
| Q45366611 | Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells |
| Q26866266 | Preclinical stem cell therapy in Chagas Disease: Perspectives for future research |
| Q34520935 | Present state and future perspectives of using pluripotent stem cells in toxicology research |
| Q37208225 | Slow turning lateral vessel bioreactor improves embryoid body formation and cardiogenic differentiation of mouse embryonic stem cells |
| Q39718626 | Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies |
| Q26865849 | Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications |
| Q57129417 | Stimulation of human embryonic stem cell-derived cardiomyocytes on thin-film microelectrodes |
| Q84329050 | Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells |
| Q39399774 | The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells |
| Q64914852 | The march of pluripotent stem cells in cardiovascular regenerative medicine. |
| Q37398305 | Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. |
| Q34604767 | Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. |